| Name | Title | Contact Details |
|---|---|---|
Michael Fry |
Director, Talent Acquisition and Compensation | Profile |
Carla Brungart |
Assistant Administrative For The Senior VP & Chief Financial Officer | Profile |
Steve Enright |
Interim SVP Human Resources | Profile |
Advantedge Healthcare Solutions (AHS) was founded in 1999 by long-time veterans of the healthcare information technology industry. We proudly serve specialty physicians with the latest RCM services and billing software.
H R Medical Supply is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MediStreams provides outsourced Healthcare Revenue Cycle Management (RCM) services for healthcare providers such as health systems, hospitals, clinics, physician groups, labs, and clinics. Despite significant advances in technology, RCM in the United States is unique and extremely complex. Although there has been a push for insurance payments to be made electronically, there are still many that arrive in the form of paper Explanation of Benefits (EOBs) combined with a traditional paper check. The Electronic Remittance Advice (ERAs) do arrive electronically and the funds are deposited to the provider`s bank, but they still must be managed and combined with other payment types to create a file that can be posted into the providers practice management software. MediStreams is now helping the industry embrace new payment technologies that leverage existing credit pipes while managing protected healthcare information. MediStreams` process automates the flow of healthcare payments by creating electronic files customized specifically to post directly to the provider`s practice management system. MediStreams` unique service delivery model accelerates the posting of remittances while eliminating errors associated with manual processing which significantly reduces provider overhead costs. MediStreams` fully HIPAA compliant platform also provides the means for payers to provide a fully reconciled payment to providers in compliance with Section 1104 of the Affordable Care Act (ACA).
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.